Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The application of MSC-derived secretome has been studied towards different pathologies by counteracting inflammation while inducing tissue regeneration namely in lung, hepatic and brain tissues.”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [160]
In the citing paper
“Nevertheless, this cell-free approach has also been reported with beneficial effects for other pathologies, including bone tissue, cardiovascular, intestinal and renal diseases [158], [159], [160], [161], [162], [163], [164], [165], [166], [167], [168], [169], [170] (Table 2).”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [160]
Citations
Cites
Bone marrow cells regenerate infarcted myocardium
Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D. M., et al. (2001) · Nature · doi:10.1038/35070587 · Cited by 5,155
Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart
Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J., & Kessler, P. D. (2002) · Circulation · doi:10.1161/hc0102.101442 · Cited by 2,234
Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells
Jackson, K. A., Majka, S. M., Wang, H., Pocius, J., Hartley, C. J., Majesky, M. W., Entman, M. L., Michael, L. H., Hirschi, K. K., & Goodell, M. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12150 · Cited by 1,960
Mangi, A. A., Noiseux, N., Kong, D., He, H., Rezvani, M., Ingwall, J. S., & Dzau, V. J. (2003) · Nature Medicine · doi:10.1038/nm912 · Cited by 1,509
Self-citationKajstura, J., Cheng, W. N., Krzysztof Reiss, F., CLARK, W. A., Sonnenblick, E. H., Krajewski, S., Reed, J., Olivetti, G., & Anversa, P. (1996) · PubMed · Cited by 1,039
Nygren, J. M., Jovinge, S., Breitbach, M., Säwén, P., Röll, W., Hescheler, J., Taneera, J., Fleischmann, B. K., & Jacobsen, S. E. W. (2004) · Nature Medicine · doi:10.1038/nm1040 · Cited by 1,037
Friedrich, J. O., Apstein, C. S., & Ingwall, J. S. (1995) · Circulation · doi:10.1161/01.cir.92.12.3527 · Cited by 43
Self-citation
Research works printed but not linked: 3
- Tomita, S. et al. Circulation 100 (19 Suppl), II247–56 (1999).
- Gnecchi, M. et al. Circulation 110 (17 Suppl), III249 (2004).
- Kajstura, J. et al. Lab. Invest. 74, 86–107 (1996).
Cited by
Extracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571
Reactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443
Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., Reinecke, H., Xu, C., Hassanipour, M., Police, S., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1327 · Cited by 2,206
“There is evidence that transplanted cells produce paracrine factors that enhance survival of host cardiomyocytes postinfarctio”
BackgroundExosome secreted by MSC reduces myocardial ischemia/reperfusion injury
Lai, R. C., Arslan, F., Lee, M. M., Sze, N. S. K., Choo, A., Chen, T. S., Salto-Tellez, M., Timmers, L., Lee, C. N., El Oakley, R. M., et al. (2010) · Stem Cell Research · doi:10.1016/j.scr.2009.12.003 · Cited by 2,215
“Recent reports have suggested that some of these reparative effects are mediated by paracrine factors secreted by MSCs (Caplan and Dennis, 2006a; Gnecchi et al., 2005, 2006; Schafer and Northoff, 2008).”
BackgroundParacrine Mechanisms in Adult Stem Cell Signaling and Therapy
Gnecchi, M., Zhang, Z., Ni, A., & Dzau, V. J. (2008) · Circulation Research · doi:10.1161/circresaha.108.176826 · Cited by 2,027
Self-citationConcise review: MSC-derived exosomes for cell-free therapy
Phinney, D. G., & Pittenger, M. F. (2017) · Stem Cells · doi:10.1002/stem.2575 · Cited by 1,834
Mesenchymal Stem Cells Enhance Wound Healing Through Differentiation and Angiogenesis
Wu, Y., Chen, L., Scott, P. G., & Tredget, E. E. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0226 · Cited by 1,676
Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper
Lener, T., Gimona, M., Aigner, L., Börger, V., Buzas, E., Camussi, G., Chaput, N., Chatterjee, D., Court, F. A., del Portillo, H. A., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.30087 · Cited by 1,491
Gnecchi, M., He, H., Noiseux, N., Liang, O. D., Zhang, L., Morello, F., Mu, H., Melo, L. G., Pratt, R. E., Ingwall, J. S., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5211com · Cited by 1,157
“These new data strengthen our recent observation on the cytoprotective properties of the Akt-MSCs (24) and strongly support the concept that the effects observed after intramyocardial injection of Akt-MSCs into infarcted hearts are to a great extent attributable to paracrine protection and functional recovery of isch-”
ResultSelf-citationMitochondrial transfer between cells can rescue aerobic respiration
Spees, J. L., Olson, S. D., Whitney, M. J., & Prockop, D. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510511103 · Cited by 1,137
Arslan, F., Lai, R. C., Smeets, M. B., Akeroyd, L., Choo, A., Aguor, E. N. E., Timmers, L., van Rijen, H. V., Doevendans, P. A., Pasterkamp, G., et al. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.01.002 · Cited by 1,107
“Most studies suggest that MSCs mediate their therapeutic efficacy through the secretion of paracrine factors (Chimenti et al., 2010; Gnecchi et al., 2005, 2006, 2008).”
BackgroundIn Search of the In Vivo Identity of Mesenchymal Stem Cells
da Silva Meirelles, L., Caplan, A. I., & Nardi, N. B. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1122 · Cited by 1,077
Meyer, G. P., Wollert, K. C., Lotz, J., Steffens, J., Lippolt, P., Fichtner, S., Hecker, H., Schaefer, A., Arseniev, L., Hertenstein, B., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.575118 · Cited by 991
Mechanisms of mesenchymal stem/stromal cell function
Spees, J. L., Lee, R. H., & Gregory, C. A. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0363-7 · Cited by 891
“inhibitor that reduces cardiomyocyte apoptosis [84–86].”
Paracrine Mechanisms of Mesenchymal Stem Cell-Based Therapy: Current Status and Perspectives
Liang, X., Ding, Y., Zhang, Y., Tse, H.-F., & Lian, Q. (2014) · Cell Transplantation · doi:10.3727/096368913x667709 · Cited by 909
Williams, A. R., & Hare, J. M. (2011) · Circulation Research · doi:10.1161/circresaha.111.243147 · Cited by 886
Signaling pathways and targeted therapy for myocardial infarction
Zhang, Q., Wang, L., Wang, S., Cheng, H., Xu, L., Pei, G., Wang, Y., Fu, C., Jiang, Y., He, C., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00925-z · Cited by 831
Stem Cell Paracrine Actions and Tissue Regeneration
Baraniak, P. R., & McDevitt, T. C. (2010) · Regenerative Medicine · doi:10.2217/rme.09.74 · Cited by 843
Mesenchymal stem cell: An efficient mass producer of exosomes for drug delivery
Yeo, R. W. Y., Lai, R. C., Zhang, B., Tan, S. S., Yin, Y., Teh, B. J., & Lim, S. K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.001 · Cited by 746
“We and others subsequently demonstrated thatMSC secretion alone could reduce infarct size in a pig and mouse model of ischemia/reperfusion injury [101,107] and improve cardiac function in a pig model of chronic ischemia [108].”
BackgroundHarnessing the Mesenchymal Stem Cell Secretome for the Treatment of Cardiovascular Disease
Ranganath, S. H., Levy, O., Inamdar, M. S., & Karp, J. M. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.02.005 · Cited by 809
“Please refer to the publisher's site for terms of use.”
BackgroundInfluentialImmunobiology of mesenchymal stem cells
Ma, S., Xie, N., Li, W., Yuan, B., Shi, Y., & Wang, Y. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.158 · Cited by 771
Exosomes: Vehicles of Intercellular Signaling, Biomarkers, and Vectors of Cell Therapy
Kourembanas, S. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021014-071641 · Cited by 761
“(73) first proposed that the effect of genetically engineered MSCs takes place in less than 72 h, before any regeneration can take place, and showed that CM from MSCs (MSC-CM) cultured in vitro have efficacy comparable to that of whole-cell transplantation in preventing ventricular remodeling.”
Rational Design of Immunomodulatory Hydrogels for Chronic Wound Healing
Kharaziha, M., Baidya, A., & Annabi, N. (2021) · Advanced Materials · doi:10.1002/adma.202100176 · Cited by 721
Bone Marrow Mesenchymal Stem Cells Stimulate Cardiac Stem Cell Proliferation and Differentiation
Hatzistergos, K. E., Quevedo, H., Oskouei, B. N., Hu, Q., Feigenbaum, G. S., Margitich, I. S., Mazhari, R., Boyle, A. J., Zambrano, J. P., Rodriguez, J. E., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.222703 · Cited by 715
Mesenchymal Stem Cells: Mechanisms of Immunomodulation and Homing
Yagi, H., Soto-Gutierrez, A., Parekkadan, B., Kitagawa, Y., Tompkins, R. G., Kobayashi, N., & Yarmush, M. L. (2010) · Cell Transplantation · doi:10.3727/096368910x508762 · Cited by 701
Rosová, I., Dao, M., Capoccia, B., Link, D., & Nolta, J. A. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1104 · Cited by 692
Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs
Chen, T. S., Lai, R. C., Lee, M. M., Choo, A. B. H., Lee, C. N., & Lim, S. K. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp857 · Cited by 658
Burridge, P. W., Keller, G., Gold, J. D., & Wu, J. C. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2011.12.013 · Cited by 670
“Because these transplanted populations do not generate new cardiomyocytes, the improvement may be due to paracrine effects that lead to enhanced vascularization (Gnecchi et al., 2005).”
Chimenti, I., Smith, R. R., Li, T.-S., Gerstenblith, G., Messina, E., Giacomello, A., & Marbán, E. (2010) · Circulation Research · doi:10.1161/circresaha.109.210682 · Cited by 660
Tögel, F., Weiss, K., Yang, Y., Hu, Z., Zhang, P., & Westenfelder, C. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00339.2006 · Cited by 641
“While the predominant belief was that improvement in outcome following organ injury and stem cell administration was the result of replacing damaged cells by differentiated stem cells, we and other groups have shown that paracrine mechanisms are primarily responsible for the organprotective actions of administered ste…”
BackgroundHow mesenchymal stem cells interact with tissue immune responses
Shi, Y., Su, J., Roberts, A. I., Shou, P., Rabson, A. B., & Ren, G. (2012) · Trends in Immunology · doi:10.1016/j.it.2011.11.004 · Cited by 633
Madrigal, M., Rao, K. S., & Riordan, N. H. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0260-8 · Cited by 615
“Gnecchi hypothesized that clinical effects of MSCs are not due to cell differentiation, after observing re-establishment of cardiac function and prevention of ventricular remodeling in fewer than 72 hours post injection [40].”
BackgroundReduction of myocardial infarct size by human mesenchymal stem cell conditioned medium
Timmers, L., Lim, S. K., Arslan, F., Armstrong, J. S., Hoefer, I. E., Doevendans, P. A., Piek, J. J., El Oakley, R. M., Choo, A., Lee, C. N., et al. (2008) · Stem Cell Research · doi:10.1016/j.scr.2008.02.002 · Cited by 617
“Recently, it has been demonstrated that rat bone marrow derived MSCs, transduced with the survival gene Akt, can protect ischemic myocardium via their paracrine secretions (Gnecchi et al., 2005).”
BackgroundPotential risks of bone marrow cell transplantation into infarcted hearts
Breitbach, M., Bostani, T., Roell, W., Xia, Y., Dewald, O., Nygren, J. M., Fries, J. W. U., Tiemann, K., Bohlen, H., Hescheler, J., et al. (2007) · Blood · doi:10.1182/blood-2006-12-063412 · Cited by 623
Uemura, R., Xu, M., Ahmad, N., & Ashraf, M. (2006) · Circulation Research · doi:10.1161/01.res.0000225952.61196.39 · Cited by 621
Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics
Armstrong, J. P. K., Holme, M. N., & Stevens, M. M. (2017) · ACS Nano · doi:10.1021/acsnano.6b07607 · Cited by 602
Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases
Lou, G., Chen, Z., Zheng, M., & Liu, Y. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.63 · Cited by 601
Quevedo, H. C., Hatzistergos, K. E., Oskouei, B. N., Feigenbaum, G. S., Rodriguez, J. E., Valdes, D., Pattany, P. M., Zambrano, J. P., Hu, Q., McNiece, I., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903201106 · Cited by 586
“Many studies have failed to document MSC differentiation into cardiac cell constituents in the infarcted heart (12, 28, 29).”
BackgroundMesenchymal stem cell exosomes
Lai, R. C., Yeo, R. W. Y., & Lim, S. K. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.03.001 · Cited by 570
“[29] Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, et al.”
BackgroundMesenchymal stem cells: a new strategy for immunosuppression and tissue repair
Shi, Y., Hu, G., Su, J., Li, W., Chen, Q., Shou, P., Xu, C., Chen, X., Huang, Y., Zhu, Z., et al. (2010) · Cell Research · doi:10.1038/cr.2010.44 · Cited by 575
Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning
Ferreira, J. R., Teixeira, G. Q., Santos, S. G., Barbosa, M. A., Almeida-Porada, G., & Gonçalves, R. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02837 · Cited by 572
Roh, J. D., Sawh-Martinez, R., Brennan, M. P., Jay, S. M., Devine, L., Rao, D. A., Yi, T., Mirensky, T. L., Nalbandian, A., Udelsman, B., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911465107 · Cited by 559
Sanganalmath, S. K., & Bolli, R. (2013) · Circulation Research · doi:10.1161/circresaha.113.300219 · Cited by 545
“One is the overexpression of antiapoptotic genes, such as heme oxygenase -1 (HO-1), B-cell lymphoma 2 (Bcl-2) Akt, or proto-oncogene serine/threonine-protein kinase (Pim-1), which has been shown to increase the survival and function of MSCs(202,209,210) and CSCs(129) including their capacity to secrete paracrine media…”
BackgroundMesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease
Lai, R. C., Chen, T. S., & Lim, S. K. (2011) · Regenerative Medicine · doi:10.2217/rme.11.35 · Cited by 553
Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy
Fan, X.-L., Zhang, Y., Li, X., & Fu, Q.-L. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03454-6 · Cited by 535
Mirotsou, M., Zhang, Z., Deb, A., Zhang, L., Gnecchi, M., Noiseux, N., Mu, H., Pachori, A., & Dzau, V. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610024104 · Cited by 545
Self-citationDai, W., Hale, S. L., Martin, B. J., Kuang, J.-Q., Dow, J. S., Wold, L. E., & Kloner, R. A. (2005) · Circulation · doi:10.1161/circulationaha.104.527937 · Cited by 539
Stem-cell-based therapy and lessons from the heart
Passier, R., van Laake, L. W., & Mummery, C. L. (2008) · Nature · doi:10.1038/nature07040 · Cited by 525
“Many cell types, derived from tissues as varied as cord blood, adipose tissue and peripheral blood, behave similarly to bone-marrow cells after being injected directly into the heart or travelling to the ischaemic site after intravenous injection, and therefore any reported improvements in cardiac function are likely…”
BackgroundExtracellular vesicles in coronary artery disease
Boulanger, C. M., Loyer, X., Rautou, P.-E., & Amabile, N. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.7 · Cited by 514
Mesenchymal Stem Cell-Derived Molecules Reverse Fulminant Hepatic Failure
Parekkadan, B., van Poll, D., Suganuma, K., Carter, E. A., Berthiaume, F., Tilles, A. W., & Yarmush, M. L. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000941 · Cited by 510
“MSCs used for cellular cardiomyoplasty after an ischemic event revealed that MSC-derived soluble molecules inhibited hypoxia-induced apoptosis of cardiomyocytes during the acute phase of injury resolution [12,13].”
BackgroundNative and bioengineered extracellular vesicles for cardiovascular therapeutics
de Abreu, R. C., Fernandes, H., da Costa Martins, P. A., Sahoo, S., Emanueli, C., & Ferreira, L. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0389-5 · Cited by 493
van Poll, D., Parekkadan, B., Cho, C. H., Berthiaume, F., Nahmias, Y., Tilles, A. W., & Yarmush, M. L. (2008) · Hepatology · doi:10.1002/hep.22236 · Cited by 501
Noiseux, N., Gnecchi, M., Lopez-Ilasaca, M., Zhang, L., Solomon, S. D., Deb, A., Dzau, V. J., & Pratt, R. E. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.016 · Cited by 496
Self-citationSicari, B. M., Rubin, J. P., Dearth, C. L., Wolf, M. T., Ambrosio, F., Boninger, M., Turner, N. J., Weber, D. J., Simpson, T. W., Wyse, A., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008085 · Cited by 491
Paracrine mechanisms of stem cell reparative and regenerative actions in the heart
Mirotsou, M., Jayawardena, T. M., Schmeckpeper, J., Gnecchi, M., & Dzau, V. J. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.08.005 · Cited by 486
“In addition to ESCs, embryonic-derived endothelial progenitor cells (eEPCs) have been shown to exhibit cytoprotective effects on both cardiomyocytes and endothelial cells exposed to hypoxia and reoxygenation by the secretion of thymosin-β4 [79], an activator of the PI3K/Akt pathway [80].”
BackgroundInfluentialSelf-citationTurturici, G., Tinnirello, R., Sconzo, G., & Geraci, F. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00228.2013 · Cited by 483
“Several studies reported that the three main mechanisms of adult stem cell action in heart repair were cardiomyocyte regeneration, vasculogenesis, and paracrine actions, the involvement of which was first reported for MSCs by Gnecchi and colleagues (66, 67, 95).”
BackgroundFeng, Y., Huang, W., Wani, M., Yu, X., & Ashraf, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088685 · Cited by 477
“MSCs transplantation has been reported to be an effective intervention for ischemic cardiomyopathy [10,11] and it has also been shown to attenuate cardiac remodeling and reduce apoptosis through paracrine factors [12,13].”
Backgroundvan Haaften, T., Byrne, R., Bonnet, S., Rochefort, G. Y., Akabutu, J., Bouchentouf, M., Rey-Parra, G. J., Galipeau, J., Haromy, A., Eaton, F., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200902-0179oc · Cited by 474
“Similar observations have been made in the heart (43).”
Paracrine Mechanisms of Mesenchymal Stem Cells in Tissue Repair
Gnecchi, M., Danieli, P., Malpasso, G., & Ciuffreda, M. C. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-3584-0_7 · Cited by 449
Self-citationLi, W., Liu, Y., Zhang, P., Tang, Y., Zhou, M., Jiang, W., Zhang, X., Wu, G., & Zhou, Y. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b17620 · Cited by 455
Hung, S.-C., Pochampally, R. R., Chen, S.-C., Hsu, S.-C., & Prockop, D. J. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0686 · Cited by 457
Mesenchymal Stem Cells in Tissue Repair
DiMarino, A. M., Caplan, A. I., & Bonfield, T. L. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00201 · Cited by 438
“For example, studies have used genetically engineered MSCs using ex vivo retroviral transduction to overexpress the pro-survival gene Akt1 (encoding the Akt protein which is important for survival) to improve overall survival of MSCs in vivo (51).”
BackgroundCardiac Stem Cells and Mechanisms of Myocardial Regeneration
Leri, A., Kajstura, J., & Anversa, P. (2005) · Physiological Reviews · doi:10.1152/physrev.00013.2005 · Cited by 451
“Reports in animals have shown that bone marrow MSCs home to the heart and promote regeneration of the infarcted myocardium in different species (434, 483), possibly involving a paracrine effect (169, 291).”
BackgroundBcl-2 Engineered MSCs Inhibited Apoptosis and Improved Heart Function
Li, W., Ma, N., Ong, L.-L., Nesselmann, C., Klopsch, C., Ladilov, Y., Furlani, D., Piechaczek, C., Moebius, J. M., Lützow, K., et al. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0771 · Cited by 440
Timmers, L., Lim, S. K., Hoefer, I. E., Arslan, F., Lai, R. C., van Oorschot, A. A. M., Goumans, M. J., Strijder, C., Sze, S. K., Choo, A., et al. (2011) · Stem Cell Research · doi:10.1016/j.scr.2011.01.001 · Cited by 430
“Recent studies suggest that at least some of the therapeutic effects of MSCs aremediated by paracrine factors secreted by the cells (Caplan & Dennis, 2006; Gnecchi et al., 2005).”
BackgroundUse of Mesenchymal Stem Cells for Therapy of Cardiac Disease
Karantalis, V., & Hare, J. M. (2015) · Circulation Research · doi:10.1161/circresaha.116.303614 · Cited by 425
“This cardioprotective effect could be enhanced when MSCs were engineered to overexpress Akt-1.(61) This was later confirmed in vivo(76) by a study showing enhanced survival of Akt-MSCs post transplantation.”
BackgroundAdipose Tissue-Derived Stem Cells in Regenerative Medicine
Frese, L., Dijkman, P. E., & Hoerstrup, S. P. (2016) · Transfusion Medicine and Hemotherapy · doi:10.1159/000448180 · Cited by 411
“The paracrine factors can improve cardiac function by reducing the apoptosis of cardiomyocytes or by activating cardiac stem cells to increase cardiomyogen-esis [36].”
Wang, X., Chen, Y., Zhao, Z., Meng, Q., Yu, Y., Sun, J., Yang, Z., Chen, Y., Li, J., Ma, T., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008737 · Cited by 422
Lee, E. Y., Xia, Y., Kim, W., Kim, M. H., Kim, T. H., Kim, K. J., Park, B., & Sung, J. (2009) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2009.00499.x · Cited by 423
“Gnecchi et al.(24,25) observed that the paracrine actions of the stem cells through the release of soluble factors were important mechanisms for tissue repair and functional improvement after injection of the Akt-transfected MSCs.”
BackgroundMunoz, J. R., Stoutenger, B. R., Robinson, A. P., Spees, J. L., & Prockop, D. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508945102 · Cited by 415
Tackling heart failure in the twenty-first century
Mudd, J. O., & Kass, D. A. (2008) · Nature · doi:10.1038/nature06798 · Cited by 406
Concise Review: Stem Cell Antigen-1: Expression, Function, and Enigma
Holmes, C., & Stanford, W. L. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0644 · Cited by 404
Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia
Roell, W., Lewalter, T., Sasse, P., Tallini, Y. N., Choi, B.-R., Breitbach, M., Doran, R., Becher, U. M., Hwang, S.-M., Bostani, T., et al. (2007) · Nature · doi:10.1038/nature06321 · Cited by 413
Jeong, J.-O., Han, J. W., Kim, J.-M., Cho, H.-J., Park, C., Lee, N., Kim, D.-W., & Yoon, Y.-S. (2011) · Circulation Research · doi:10.1161/circresaha.110.239848 · Cited by 410
Iso, Y., Spees, J. L., Serrano, C., Bakondi, B., Pochampally, R., Song, Y.-H., Sobel, B. E., Delafontaine, P., & Prockop, D. J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.045 · Cited by 404
“The therapeutic potential of secreted factors from adult stem/progenitor cells has been recognized [13], [14], [15], [16] and [17].”
BackgroundResultChen, T. S., Arslan, F., Yin, Y., Tan, S. S., Lai, R. C., Choo, A. B. H., Padmanabhan, J., Lee, C. N., de Kleijn, D. P., & Lim, S. K. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-47 · Cited by 397
“In recent years, MSC transplantations have demonstrated therapeutic efficacy in treating different diseases but the underlying mechanism has been controversial [2-9].”
BackgroundTherapeutic potential of mesenchymal stem cell-derived microvesicles
Biancone, L., Bruno, S., Deregibus, M. C., Tetta, C., & Camussi, G. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs168 · Cited by 393
“[14] showed that CM from MSCs overexpressing the Akt gene (Akt-MSCs) reduced infarct size in a rodent model of acute myocardial infarction as efficiently as the actual MSCs.”
BackgroundBrennan, M. Á., Layrolle, P., & Mooney, D. J. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909125 · Cited by 396
Life and Death of Cardiac Stem Cells: A Paradigm Shift in Cardiac Biology
Anversa, P., Kajstura, J., Leri, A., & Bolli, R. (2006) · Circulation · doi:10.1161/circulationaha.105.595181 · Cited by 387
Börger, V., Bremer, M., Ferrer-Tur, R., Gockeln, L., Stambouli, O., Becic, A., & Giebel, B. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071450 · Cited by 371
“To best of our knowledge, Gnecchi and colleagues were the first who showed in the example of a rat ischemic heart model that the effects of MSCs were mediated in a paracrine manner [12].”
BackgroundCardiac Stem Cell Therapy and the Promise of Heart Regeneration
Garbern, J. C., & Lee, R. T. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.05.008 · Cited by 369
Fibroblast growth factor 21 protects against cardiac hypertrophy in mice
Planavila, A., Redondo, I., Hondares, E., Vinciguerra, M., Munts, C., Iglesias, R., Gabrielli, L. A., Sitges, M., Giralt, M., van Bilsen, M., et al. (2013) · Nature Communications · doi:10.1038/ncomms3019 · Cited by 371
Sluijter, J. P. G., Davidson, S. M., Boulanger, C. M., Buzás, E. I., de Kleijn, D. P. V., Engel, F. B., Giricz, Z., Hausenloy, D. J., Kishore, R., Lecour, S., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvx211 · Cited by 355
Murry, C. E., Reinecke, H., & Pabon, L. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.02.002 · Cited by 360
Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway
Shiojima, I., & Walsh, K. (2006) · Genes & Development · doi:10.1101/gad.1492806 · Cited by 356
“…and conditioned media obtained from Akt-overexpressing mesenchymal stem cells also improve contractility, suggesting that paracrine factors released from mesenchymal stem cells in response to Akt activation account for the early improvement of contractile function (Gnecchi et al. 2005, 2006).”
BackgroundNovel Cardiac Precursor-Like Cells from Human Menstrual Blood-Derived Mesenchymal Cells
Hida, N., Nishiyama, N., Miyoshi, S., Kira, S., Segawa, K., Uyama, T., Mori, T., Miyado, K., Ikegami, Y., Cui, C., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0826 · Cited by 342
Katare, R., Riu, F., Mitchell, K., Gubernator, M., Campagnolo, P., Cui, Y., Fortunato, O., Avolio, E., Cesselli, D., Beltrami, A. P., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.251546 · Cited by 344
Golpanian, S., Wolf, A., Hatzistergos, K. E., & Hare, J. M. (2016) · Physiological Reviews · doi:10.1152/physrev.00019.2015 · Cited by 343
“These effects were observed rather early ( 72 h post-infarction) and thus were suggested to be due to myocardial protection and enhancement of cardiac function rather than donor-cell engraftment and/or cardiomyogenesis (114, 115).”
BackgroundKolossov, E., Bostani, T., Roell, W., Breitbach, M., Pillekamp, F., Nygren, J. M., Sasse, P., Rubenchik, O., Fries, J. W. U., Wenzel, D., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061469 · Cited by 335
Ionescu, L., Byrne, R. N., van Haaften, T., Vadivel, A., Alphonse, R. S., Rey-Parra, G. J., Weissmann, G., Hall, A., Eaton, F., & Thébaud, B. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00144.2011 · Cited by 323
“Recent studies have shown that MSCs modulate immune cell function (28, 39, 46) and have cell-protective effects through the release of cytokines and growth factors (17, 18, 24, 37).”
BackgroundStem Cell Extracellular Vesicles: Extended Messages of Regeneration
Riazifar, M., Pone, E. J., Lötvall, J., & Zhao, W. (2017) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061616-030146 · Cited by 323
Casado-Díaz, A., Quesada-Gómez, J. M., & Dorado, G. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00146 · Cited by 313
“For instance, that has been demonstrated in rodent models of acute myocardial infarction (Gnecchi et al., 2005; El Andaloussi et al., 2013).”
BackgroundDerivation of Clinically Compliant MSCs from CD105+, CD24− Differentiated Human ESCs
Lian, Q., Lye, E., Suan Yeo, K., Khia Way Tan, E., Salto-Tellez, M., Liu, T. M., Palanisamy, N., El Oakley, R. M., Lee, E. H., Lim, B., et al. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0420 · Cited by 317
Hahn, J.-Y., Cho, H.-J., Kang, H.-J., Kim, T.-S., Kim, M.-H., Chung, J.-H., Bae, J.-W., Oh, B.-H., Park, Y.-B., & Kim, H.-S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.11.040 · Cited by 313
“substantial portion of the salutary effects of MSC imlantation might be attributable to salvage of endangered schemic myocardium (5).”
BackgroundRecent advances into the understanding of mesenchymal stem cell trafficking
Fox, J. M., Chamberlain, G., Ashton, B. A., & Middleton, J. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06610.x · Cited by 303
“This indicated that secreted factors from MSC were responsible for the observed cardiac improvements after MI (Gnecchi et al, 2005, 2006).”
BackgroundAdult Stem Cell Therapy and Heart Failure, 2000 to 2016: A Systematic Review
Nguyen, P. K., Rhee, J.-W., & Wu, J. C. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2225 · Cited by 299
Yang, F., Cho, S.-W., Son, S. M., Bogatyrev, S. R., Singh, D., Green, J. J., Mei, Y., Park, S., Bhang, S. H., Kim, B.-S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905432106 · Cited by 301
“Genetic modification of MSCs with Akt or Bcl-2 gene also improved the therapeutic efficacy of cell transplantation in treating myocardium (11, 12).”
BackgroundAisagbonhi, O., Rai, M., Ryzhov, S., Atria, N., Feoktistov, I., & Hatzopoulos, A. K. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.006510 · Cited by 302
“Instead, the current evidence suggests that donor cells exert a favorable paracrine effect on the injured myocardium, preventing apoptosis and promoting healing (Heil et al., 2004; Kupatt et al., 2005b; Gnecchi et al., 2005; Uemura et al., 2006).”
Qiao, L., Hu, S., Liu, S., Zhang, H., Ma, H., Huang, K., Li, Z., Su, T., Vandergriff, A., Tang, J., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123135 · Cited by 303
“The secretome from the injected cells enhances cardiomyocyte proliferation, promotes neovascularization, and inhibits cardiomyocyte apoptosis (15, 35).”
BackgroundThe Immunomodulatory Functions of Mesenchymal Stromal/Stem Cells Mediated via Paracrine Activity
Zhou, Y., Yamamoto, Y., Xiao, Z., & Ochiya, T. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8071025 · Cited by 303
“Based on the observation that BM-MSCs strongly suppress T lymphocyte proliferation due to the production of soluble factors, emerging evidence suggests that the secretion of bioactive factors, including chemokines and cytokines, contributes to the broad effects of MSCs on the cells of the innate and adaptive immune sy…”
BackgroundInfluential
Metadata
- Authors
- Gnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R. E., Ingwall, J. S., & Dzau, V. J.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Dzau, Victor J
- ORCID
- Venue
- Nature Medicine
- Published
- 2005-04
- Volume
- 11
- Issue
- 4
- Pages
- 367-368
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2067591094
- Cited by
- 1,677
- References
- 7
- Citations by year
- 2026: 31 · 2025: 35 · 2024: 49 · 2023: 55 · 2022: 67 · 2021: 86 · 2020: 91 · 2019: 69 · 2018: 74 · 2017: 87 · 2016: 95 · 2015: 89 · 2014: 81 · 2013: 88 · 2012: 106
- FWCI
- 38.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Funders
- National Institutes of Health (1z01hl005320-01)
- National Heart, Lung, and Blood Institute (HL 73219, HL-58516, HL 72010, R01HL063985, HL 5320, R01HL058516, R01HL072010, HL-35610, R01HL073219, HL 63985)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- paracrine signaling, mesenchymal stem cells, Akt signaling, myocardial ischemia, cardioprotection, cell therapy, exosomes, secretome
- MeSH terms
- Animals, Cells, Cultured, Myocardial Infarction, Myocardium, Proto-Oncogene Proteins, Cell Hypoxia, Bone Marrow Transplantation, Culture Media, Conditioned, Apoptosis, Protein Serine-Threonine Kinases, Intercellular Signaling Peptides and Proteins, Mesenchymal Stem Cell Transplantation, Green Fluorescent Proteins, Proto-Oncogene Proteins c-akt, Rats, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.